| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NGVT Stock Overview
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America.
Ingevity Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$63.72 |
| 52 Week High | US$88.58 |
| 52 Week Low | US$56.31 |
| Beta | 1.96 |
| 1 Month Change | -9.30% |
| 3 Month Change | -2.01% |
| 1 Year Change | -20.07% |
| 3 Year Change | -38.30% |
| 5 Year Change | 12.62% |
| Change since IPO | 137.23% |
Recent News & Updates
Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?
Ingevity Corporation ( NYSE:NGVT ), might not be a large cap stock, but it led the NYSE gainers with a relatively large...
Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist
Ingevity is a small, niche, specialty chemicals producer with fairly strong fundamentals, but a few issues to consider. As the price falls, the valuation becomes much more enticing. If issues begin to be offset over the next few quarters, I believe the company is worth further consideration.
Shareholder Returns
| NGVT | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 1.8% | -0.05% | 1.7% |
| 1Y | -20.1% | -10.0% | -20.4% |
Return vs Industry: NGVT underperformed the US Chemicals industry which returned -9% over the past year.
Return vs Market: NGVT underperformed the US Market which returned -18.8% over the past year.
Price Volatility
| NGVT volatility | |
|---|---|
| NGVT Average Weekly Movement | 5.2% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: NGVT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: NGVT's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 1,850 | John Fortson | https://www.ingevity.com |
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats.
Ingevity Fundamentals Summary
| NGVT fundamental statistics | |
|---|---|
| Market Cap | US$2.47b |
| Earnings (TTM) | US$130.20m |
| Revenue (TTM) | US$1.45b |
19.0x
P/E Ratio1.7x
P/S RatioIs NGVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NGVT income statement (TTM) | |
|---|---|
| Revenue | US$1.45b |
| Cost of Revenue | US$929.60m |
| Gross Profit | US$524.40m |
| Other Expenses | US$394.20m |
| Earnings | US$130.20m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.36 |
| Gross Margin | 36.07% |
| Net Profit Margin | 8.95% |
| Debt/Equity Ratio | 169.7% |
How did NGVT perform over the long term?
See historical performance and comparisonValuation
Is NGVT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NGVT?
Other financial metrics that can be useful for relative valuation.
| What is NGVT's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$2.47b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.5x |
| Enterprise Value/EBITDA | 8.3x |
| PEG Ratio | 1.1x |
Price to Earnings Ratio vs Peers
How does NGVT's PE Ratio compare to its peers?
| NGVT PE Ratio vs Peers |
|---|
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 49.4x | ||
SCL Stepan | 15.8x | 11.0% | US$2.3b |
IOSP Innospec | 22.2x | 18.5% | US$2.3b |
GCP GCP Applied Technologies | 142.4x | n/a | US$2.3b |
NEU NewMarket | 17x | n/a | US$3.1b |
NGVT Ingevity | 19x | 17.3% | US$2.5b |
Price-To-Earnings vs Peers: NGVT is good value based on its Price-To-Earnings Ratio (19x) compared to the peer average (49.4x).
Price to Earnings Ratio vs Industry
How does NGVT's PE Ratio compare vs other companies in the US Chemicals Industry?
Price-To-Earnings vs Industry: NGVT is expensive based on its Price-To-Earnings Ratio (19x) compared to the US Chemicals industry average (16x)
Price to Earnings Ratio vs Fair Ratio
What is NGVT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 19x |
| Fair PE Ratio | 19.2x |
Price-To-Earnings vs Fair Ratio: NGVT is good value based on its Price-To-Earnings Ratio (19x) compared to the estimated Fair Price-To-Earnings Ratio (19.2x).
Share Price vs Fair Value
What is the Fair Price of NGVT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NGVT ($63.72) is trading below our estimate of fair value ($144.25)
Significantly Below Fair Value: NGVT is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: NGVT is poor value based on its PEG Ratio (1.1x)
Discover undervalued companies
Future Growth
How is Ingevity forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score
2/6Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
17.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NGVT's forecast earnings growth (17.3% per year) is above the savings rate (1.9%).
Earnings vs Market: NGVT's earnings (17.3% per year) are forecast to grow faster than the US market (13.8% per year).
High Growth Earnings: NGVT's earnings are forecast to grow, but not significantly.
Revenue vs Market: NGVT's revenue (4.6% per year) is forecast to grow slower than the US market (8.3% per year).
High Growth Revenue: NGVT's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NGVT's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Past Performance
How has Ingevity performed over the past 5 years?
Past Performance Score
1/6Past Performance Score 1/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
10.1%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NGVT has a large one-off loss of $101.2M impacting its March 31 2022 financial results.
Growing Profit Margin: NGVT's current net profit margins (9%) are lower than last year (14.8%).
Past Earnings Growth Analysis
Earnings Trend: NGVT's earnings have grown by 10.1% per year over the past 5 years.
Accelerating Growth: NGVT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NGVT had negative earnings growth (-29.5%) over the past year, making it difficult to compare to the Chemicals industry average (30.2%).
Return on Equity
High ROE: NGVT's Return on Equity (19%) is considered low.
Discover strong past performing companies
Financial Health
How is Ingevity's financial position?
Financial Health Score
4/6Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: NGVT's short term assets ($732.8M) exceed its short term liabilities ($551.7M).
Long Term Liabilities: NGVT's short term assets ($732.8M) do not cover its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: NGVT's net debt to equity ratio (137.3%) is considered high.
Reducing Debt: NGVT's debt to equity ratio has reduced from 265% to 169.7% over the past 5 years.
Debt Coverage: NGVT's debt is well covered by operating cash flow (22.9%).
Interest Coverage: NGVT's interest payments on its debt are well covered by EBIT (6.9x coverage).
Balance Sheet
Discover healthy companies
Dividend
What is Ingevity current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NGVT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NGVT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NGVT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NGVT's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NGVT has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
1.3yrs
Average management tenure
CEO
John Fortson (54 yo)
1.75yrs
Tenure
US$4,822,288
Compensation
Mr. John C. Fortson serves as President, Chief Executive Officer and Director at Ingevity Corporation since September 01, 2020. He served as Interim Chief Financial Officer and Treasurer at Ingevity Corpor...
CEO Compensation Analysis
Compensation vs Market: John's total compensation ($USD4.82M) is about average for companies of similar size in the US market ($USD6.87M).
Compensation vs Earnings: John's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Leadership Team
Experienced Management: NGVT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Experienced Board: NGVT's board of directors are considered experienced (6.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Ingevity Corporation's employee growth, exchange listings and data sources
Key Information
- Name: Ingevity Corporation
- Ticker: NGVT
- Exchange: NYSE
- Founded: 1964
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: US$2.469b
- Shares outstanding: 38.75m
- Website: https://www.ingevity.com
Number of Employees
Location
- Ingevity Corporation
- 4920 O'Hear Avenue
- Suite 400
- North Charleston
- South Carolina
- 29405
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/28 00:00 |
| End of Day Share Price | 2022/06/28 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.